| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
|
N Engl J Med
|
2004
|
5.36
|
|
2
|
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.
|
Blood
|
2003
|
2.53
|
|
3
|
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).
|
Haematologica
|
2007
|
2.03
|
|
4
|
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.
|
J Clin Oncol
|
2012
|
1.74
|
|
5
|
Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database.
|
J Clin Oncol
|
2012
|
1.56
|
|
6
|
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
|
J Clin Oncol
|
2006
|
1.46
|
|
7
|
Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.
|
J Clin Microbiol
|
2005
|
1.38
|
|
8
|
More on Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma.
|
N Engl J Med
|
2017
|
1.38
|
|
9
|
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.
|
Haematologica
|
2009
|
1.34
|
|
10
|
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
|
Br J Haematol
|
2009
|
1.34
|
|
11
|
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
|
J Clin Oncol
|
2008
|
1.25
|
|
12
|
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.
|
Blood
|
2008
|
1.21
|
|
13
|
Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
|
Transplantation
|
2013
|
1.18
|
|
14
|
Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
|
Transfusion
|
2007
|
1.16
|
|
15
|
Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.
|
J Hematol Oncol
|
2012
|
1.16
|
|
16
|
Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response?
|
Hum Gene Ther
|
2008
|
1.12
|
|
17
|
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
|
Br J Haematol
|
2010
|
1.10
|
|
18
|
The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study.
|
Blood
|
2004
|
1.08
|
|
19
|
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
|
Biol Blood Marrow Transplant
|
2013
|
1.07
|
|
20
|
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.
|
Hematol J
|
2004
|
1.06
|
|
21
|
Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France.
|
Haematologica
|
2013
|
1.02
|
|
22
|
Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.
|
Haematologica
|
2011
|
1.00
|
|
23
|
Increased risk of non-Hodgkin lymphoma and serum organochlorine concentrations among neighbors of a municipal solid waste incinerator.
|
Environ Int
|
2010
|
0.95
|
|
24
|
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
|
Exp Hematol
|
2008
|
0.94
|
|
25
|
Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance.
|
Blood
|
2010
|
0.94
|
|
26
|
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.
|
Blood
|
2004
|
0.93
|
|
27
|
c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome.
|
Br J Haematol
|
2005
|
0.92
|
|
28
|
Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
|
Liver Transpl
|
2009
|
0.91
|
|
29
|
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.
|
Haematologica
|
2010
|
0.91
|
|
30
|
Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.
|
Clin Pharmacokinet
|
2009
|
0.90
|
|
31
|
Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors.
|
Transfusion
|
2010
|
0.88
|
|
32
|
Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.
|
Exp Hematol
|
2013
|
0.88
|
|
33
|
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
|
Eur J Haematol
|
2013
|
0.88
|
|
34
|
Benchmarking of QSAR models for blood-brain barrier permeation.
|
J Chem Inf Model
|
2007
|
0.86
|
|
35
|
Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
|
J Clin Oncol
|
2010
|
0.85
|
|
36
|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
|
Bioorg Med Chem
|
2007
|
0.83
|
|
37
|
G-CSF-induced aneuploidy does not affect CD34+ cells and does not require cell division.
|
Blood
|
2010
|
0.82
|
|
38
|
Azole-resistant Aspergillus fumigatus isolate with the TR34/L98H mutation in both a fungicide-sprayed field and the lung of a hematopoietic stem cell transplant recipient with invasive aspergillosis.
|
J Clin Microbiol
|
2014
|
0.82
|
|
39
|
Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft.
|
Blood
|
2007
|
0.82
|
|
40
|
Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation.
|
Haematologica
|
2005
|
0.81
|
|
41
|
A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, did not induce autoimmunity.
|
J Hematother Stem Cell Res
|
2003
|
0.81
|
|
42
|
Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis.
|
Cytometry A
|
2012
|
0.81
|
|
43
|
CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry.
|
Cytometry A
|
2011
|
0.81
|
|
44
|
[Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification].
|
Bull Cancer
|
2006
|
0.81
|
|
45
|
Pharmacokinetics of mycophenolic acid administered 3 times daily after hematopoietic stem cell transplantation with reduced-intensity regimen.
|
Biol Blood Marrow Transplant
|
2009
|
0.80
|
|
46
|
Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphoma.
|
Pharmacoeconomics
|
2009
|
0.80
|
|
47
|
Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
|
APMIS
|
2011
|
0.79
|
|
48
|
Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
|
Cancer
|
2014
|
0.79
|
|
49
|
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
|
Haematologica
|
2006
|
0.78
|
|
50
|
Comparison and combination of spectroscopic techniques for the detection of counterfeit medicines.
|
J Pharm Biomed Anal
|
2010
|
0.77
|
|
51
|
Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases.
|
Transplantation
|
2002
|
0.77
|
|
52
|
Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation.
|
Blood
|
2011
|
0.77
|
|
53
|
Impurity fingerprints for the identification of counterfeit medicines--a feasibility study.
|
Anal Chim Acta
|
2011
|
0.77
|
|
54
|
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
|
Eur J Haematol
|
2014
|
0.77
|
|
55
|
Systematic donor blood qualification by flow cytometry would have been able to avoid CLL-type MBL transmission after unrelated hematopoietic stem cell transplantation.
|
Eur J Haematol
|
2012
|
0.76
|
|
56
|
Long-term follow-up of tandem high-dose therapy with autologous stem cell support for adults with high-risk age-adjusted international prognostic index aggressive non-Hodgkin Lymphomas: a GOELAMS pilot study.
|
Biol Blood Marrow Transplant
|
2010
|
0.76
|
|
57
|
Modelling aluminium leaching into food from different foodware materials with multi-level factorial design of experiments.
|
Food Addit Contam Part A Chem Anal Control Expo Risk Assess
|
2012
|
0.75
|
|
58
|
Renal toxicity after bone marrow transplantation.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.75
|
|
59
|
Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin's Lymphoma.
|
Clin Drug Investig
|
2005
|
0.75
|
|
60
|
Development and validation of a ultra-high-performance liquid chromatography-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicines.
|
J Chromatogr A
|
2011
|
0.75
|
|
61
|
In vitro Dermal Absorption of Hydroquinone: Protocol Validation and Applicability on Illegal Skin-Whitening Cosmetics.
|
Skin Pharmacol Physiol
|
2017
|
0.75
|
|
62
|
Statistical confidence for variable selection in QSAR models via Monte Carlo cross-validation.
|
J Chem Inf Model
|
2008
|
0.75
|
|
63
|
In vitro Dermal Absorption: Sample Application and Seal Quality in a Franz Diffusion Cell System.
|
Skin Pharmacol Physiol
|
2015
|
0.75
|
|
64
|
Detection of counterfeit Viagra® by Raman microspectroscopy imaging and multivariate analysis.
|
J Pharm Biomed Anal
|
2011
|
0.75
|
|
65
|
Opposing Mcl-1, the GALIG proapoptotic gene is upregulated as neutrophils die and underexpressed in Acute Myeloid Leukemia cells.
|
Mol Immunol
|
2013
|
0.75
|
|
66
|
Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604.
|
Drug Test Anal
|
2014
|
0.75
|
|
67
|
Fatal thrombotic thrombocytopenic purpura in a psoriasis patient treated with ustekinumab and methotrexate.
|
Acta Derm Venereol
|
2015
|
0.75
|
|
68
|
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
|
Invest New Drugs
|
2011
|
0.75
|
|
69
|
Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
|
Eur J Haematol
|
2014
|
0.75
|
|
70
|
Identification of the small research tetra peptide Epitalon, assumed to be a potential treatment for cancer, old age and Retinitis Pigmentosa in two illegal pharmaceutical preparations.
|
Drug Test Anal
|
2014
|
0.75
|
|
71
|
[Economic impact of outpatient chemotherapy in multiple myeloma].
|
Bull Cancer
|
2004
|
0.75
|